Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA: 2010-2025

Historic EBITDA for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $4.7 million.

  • Mesa Laboratories' EBITDA rose 34.66% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 105.73%. This contributed to the annual value of $16.3 million for FY2025, which is 106.00% up from last year.
  • Latest data reveals that Mesa Laboratories reported EBITDA of $4.7 million as of Q3 2025, which was up 54.18% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' EBITDA registered a high of $5.8 million during Q4 2024, and its lowest value of -$271.3 million during Q1 2024.
  • Its 3-year average for EBITDA is -$22.5 million, with a median of $1.5 million in 2025.
  • Data for Mesa Laboratories' EBITDA shows a peak YoY increase of 8,725.37% (in 2024) and a maximum YoY decrease of 52,572.73% (in 2024) over the last 5 years.
  • Over the past 5 years, Mesa Laboratories' EBITDA (Quarterly) stood at -$2.5 million in 2021, then skyrocketed by 235.43% to $3.4 million in 2022, then plummeted by 101.97% to -$67,000 in 2023, then soared by 8,725.37% to $5.8 million in 2024, then soared by 34.66% to $4.7 million in 2025.
  • Its EBITDA stands at $4.7 million for Q3 2025, versus $3.1 million for Q2 2025 and $1.5 million for Q1 2025.